FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4246960462> ?p ?o ?g. }

• W4246960462 endingPage "4316" @default.
• W4246960462 startingPage "4316" @default.
• W4246960462 abstract "Abstract Ovarian cancer (OCa) is the deadliest of all gynecologic cancers in the United States and a critical need exists for the development of novel therapies for the treatment of OCa. Leukemia inhibitory factor receptor (LIFR) and its ligand LIF play a critical role in cancer progression, metastasis, stem cell maintenance, and therapy resistance. Recent clinical studies showed that cancer cells elucidate feedback activation of LIFR that limits response to histone deacetylase (HDAC) inhibitors. Recently, we developed a first-in-class inhibitor of LIFR, EC359 that directly interacts with LIFR and effectively blocks LIF-LIFR interactions. Here, we examined whether LIFR inhibitor EC359 abrogate the side effects of histone deacetylase inhibitor SAHA (Vorinostat) for the treatment of OCa. Methods: The effect of EC359 and SAHA as a combination therapy on OCa cell viability was examined by MTT assays. The efficacy of combination therapy on cell survival and apoptosis was determined using clonogenic assays and caspase3/7 assays respectively. The efficacy of combination therapy on OCa stem cells was determined using extreme limiting dilution assays. Mechanistic studies were performed using western blotting, qRT-PCR and Mass Spectrometry analyses. The effect of combination therapy on STAT3 signaling was examined using reporter gene assays. The in vivo efficacy of combination therapy on tumors was examined using ex vivopatient derived explants and mouse xenograft models. Results: EC359 significantly enhanced the efficacy of SAHA in reducing cell viability, colony formation ability, and apoptosis compared to monotherapy of SAHA in multiple established and primary OCa cells. Further, EC359 enhanced SAHA ability to reduce self-renewal of OCa stem cells. As expected in STAT3 reporter assays, SAHA treatment activated STAT3 reporter and EC359 addition abrogated SAHA mediated STAT3 activation. Mechanistic studies using multiple OCa models and western blot analysis confirmed activation of LIFR signaling pathway upon SAHA treatment and its blockage by EC359 treatment. Treatment of human primary OCa tumor explants with EC359 enhanced ability of SAHA to decrease the proliferation (Ki-67 positivity) compared to monotherapy treated tumors. DIA based Mass Spectrometry analyses identified unique pathways modulated by combination therapy. Treatment of OCa xenografts with EC359 enhanced the ability of SAHA to reduce in vivotumor growth compared to monotherapy treated tumors. Conclusions: Our results suggest that EC359 has therapeutic utility in overcoming the limitation of feedback activation of LIFR observed in the treatment of HDAC inhibitors in treating OCa. Citation Format: Mengxing Li, Suryavathi Viswanadhapalli, Gangadhara Reddy Sareddy, Bindu Santhamma, Hui Yan, Zhenming Xu, Edward Kost, Rajeshwar Rao Tekmal, Hareesh B. Nair, Klaus J. Nickisch, Ratna K. Vadlamudi. Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4316." @default.
• W4246960462 created "2022-05-12" @default.
• W4246960462 creator A5013647410 @default.
• W4246960462 creator A5043867874 @default.
• W4246960462 creator A5052297870 @default.
• W4246960462 creator A5054763940 @default.
• W4246960462 creator A5060877175 @default.
• W4246960462 creator A5070750570 @default.
• W4246960462 creator A5072990107 @default.
• W4246960462 creator A5074314607 @default.
• W4246960462 creator A5075694762 @default.
• W4246960462 creator A5077133681 @default.
• W4246960462 creator A5090010000 @default.
• W4246960462 date "2019-07-01" @default.
• W4246960462 modified "2023-09-27" @default.
• W4246960462 title "Abstract 4316: Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer" @default.
• W4246960462 doi "https://doi.org/10.1158/1538-7445.am2019-4316" @default.
• W4246960462 hasPublicationYear "2019" @default.
• W4246960462 type Work @default.
• W4246960462 citedByCount "0" @default.
• W4246960462 crossrefType "journal-article" @default.
• W4246960462 hasAuthorship W4246960462A5013647410 @default.
• W4246960462 hasAuthorship W4246960462A5043867874 @default.
• W4246960462 hasAuthorship W4246960462A5052297870 @default.
• W4246960462 hasAuthorship W4246960462A5054763940 @default.
• W4246960462 hasAuthorship W4246960462A5060877175 @default.
• W4246960462 hasAuthorship W4246960462A5070750570 @default.
• W4246960462 hasAuthorship W4246960462A5072990107 @default.
• W4246960462 hasAuthorship W4246960462A5074314607 @default.
• W4246960462 hasAuthorship W4246960462A5075694762 @default.
• W4246960462 hasAuthorship W4246960462A5077133681 @default.
• W4246960462 hasAuthorship W4246960462A5090010000 @default.
• W4246960462 hasConcept C104317684 @default.
• W4246960462 hasConcept C106825092 @default.
• W4246960462 hasConcept C117262875 @default.
• W4246960462 hasConcept C11988809 @default.
• W4246960462 hasConcept C121608353 @default.
• W4246960462 hasConcept C126322002 @default.
• W4246960462 hasConcept C185592680 @default.
• W4246960462 hasConcept C190283241 @default.
• W4246960462 hasConcept C203014093 @default.
• W4246960462 hasConcept C27284151 @default.
• W4246960462 hasConcept C2776202225 @default.
• W4246960462 hasConcept C2776262904 @default.
• W4246960462 hasConcept C2778305200 @default.
• W4246960462 hasConcept C2778690821 @default.
• W4246960462 hasConcept C502942594 @default.
• W4246960462 hasConcept C53227056 @default.
• W4246960462 hasConcept C55493867 @default.
• W4246960462 hasConcept C64927066 @default.
• W4246960462 hasConcept C71924100 @default.
• W4246960462 hasConcept C86803240 @default.
• W4246960462 hasConcept C96232424 @default.
• W4246960462 hasConceptScore W4246960462C104317684 @default.
• W4246960462 hasConceptScore W4246960462C106825092 @default.
• W4246960462 hasConceptScore W4246960462C117262875 @default.
• W4246960462 hasConceptScore W4246960462C11988809 @default.
• W4246960462 hasConceptScore W4246960462C121608353 @default.
• W4246960462 hasConceptScore W4246960462C126322002 @default.
• W4246960462 hasConceptScore W4246960462C185592680 @default.
• W4246960462 hasConceptScore W4246960462C190283241 @default.
• W4246960462 hasConceptScore W4246960462C203014093 @default.
• W4246960462 hasConceptScore W4246960462C27284151 @default.
• W4246960462 hasConceptScore W4246960462C2776202225 @default.
• W4246960462 hasConceptScore W4246960462C2776262904 @default.
• W4246960462 hasConceptScore W4246960462C2778305200 @default.
• W4246960462 hasConceptScore W4246960462C2778690821 @default.
• W4246960462 hasConceptScore W4246960462C502942594 @default.
• W4246960462 hasConceptScore W4246960462C53227056 @default.
• W4246960462 hasConceptScore W4246960462C55493867 @default.
• W4246960462 hasConceptScore W4246960462C64927066 @default.
• W4246960462 hasConceptScore W4246960462C71924100 @default.
• W4246960462 hasConceptScore W4246960462C86803240 @default.
• W4246960462 hasConceptScore W4246960462C96232424 @default.
• W4246960462 hasIssue "13_Supplement" @default.
• W4246960462 hasLocation W42469604621 @default.
• W4246960462 hasOpenAccess W4246960462 @default.
• W4246960462 hasPrimaryLocation W42469604621 @default.
• W4246960462 hasRelatedWork W139517961 @default.
• W4246960462 hasRelatedWork W2005745992 @default.
• W4246960462 hasRelatedWork W2032365508 @default.
• W4246960462 hasRelatedWork W2067689002 @default.
• W4246960462 hasRelatedWork W2079180410 @default.
• W4246960462 hasRelatedWork W2124373649 @default.
• W4246960462 hasRelatedWork W2140928316 @default.
• W4246960462 hasRelatedWork W2740863466 @default.
• W4246960462 hasRelatedWork W2954474636 @default.
• W4246960462 hasRelatedWork W2955516014 @default.
• W4246960462 hasVolume "79" @default.
• W4246960462 isParatext "false" @default.
• W4246960462 isRetracted "false" @default.
• W4246960462 workType "article" @default.